8-K current report · filed Sep 10, 2026

IBEX Ltd (IBEX) 8-K Current Report: September 10, 2026

Item 1.01Item EX-99.1Item 2.02Item 2.03IBEX overview

Short answer

IBEX Ltd (IBEX) filed an 8-K current report with the SEC on September 10, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation). U.S. and UAE credit maturities extended to October 22, 2029, improving near-term refinancing flexibility.

IBEX Ltd 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • U.S. and UAE credit maturities extended to October 22, 2029, improving near-term refinancing flexibility
  • U.S. facility: $25 million secured revolver with 0.20% closing fee and 0.30% annual fee on unused capacity
  • UAE facilities retain $50 million post-shipment seller revolver and $50,000 credit card facility
  • UAE agreement adds a $1 million performance bond facility
  • UAE receivables pledged as collateral, capped at $58.905 million, increasing lender security claims

Item 2.02 · Results of Operations and Financial Condition

  • IBEX reported fourth-quarter and fiscal-year results for the period ended June 30, 2026
  • Exhibit 99.1 contains the press release with the financial results and management commentary
  • Annual results provide investors a full-year view of IBEX’s operating performance and financial condition

Item 2.03 · Creation of a Direct Financial Obligation

  • Item 2.03 creates a direct financial obligation through the material agreement described under Item 1.01
  • Investor impact depends on Item 1.01 terms, including obligation amount, interest rate, maturity and purpose

Item EX-99.1 · Exhibit EX-99.1

  • FY2026 revenue $644.1M, up 15.4%, with HealthTech up 38.5% and Technology up 25.6%
  • FY2026 diluted EPS $3.13, up 32.8%, while adjusted EPS reached $3.52, up 28.3%
  • FY2026 adjusted EBITDA $82.4M, up 14.5%, but margin eased to 12.8% from 12.9%
  • Record operating cash flow $59.0M and free cash flow $31.2M, with net cash rising to $30.9M
  • FY2027 guidance: revenue $700-$715M and adjusted EBITDA $90-$94M, implying continued 9-14% growth

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other IBEX Ltd 8-K filings

Get the next IBEX 8-K as it lands

Follow IBEX for push alerts, or ask the research agent what this filing means.